Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

In Silico Identification and Experimental Validation of (-)-Muqubilin A, a Marine Norterpene Peroxide, as PPARα/γ-RXRα Agonist and RARα Positive Allosteric Modulator.

D'Aniello E, Iannotti FA, Falkenberg LG, Martella A, Gentile A, De Maio F, Ciavatta ML, Gavagnin M, Waxman JS, Di Marzo V, Amodeo P, Vitale RM.

Mar Drugs. 2019 Feb 12;17(2). pii: E110. doi: 10.3390/md17020110.

2.

Identification and characterization of phytocannabinoids as novel dual PPARα/γ agonists by a computational and in vitro experimental approach.

D'Aniello E, Fellous T, Iannotti FA, Gentile A, Allarà M, Balestrieri F, Gray R, Amodeo P, Vitale RM, Di Marzo V.

Biochim Biophys Acta Gen Subj. 2019 Mar;1863(3):586-597. doi: 10.1016/j.bbagen.2019.01.002. Epub 2019 Jan 3.

PMID:
30611848
3.

Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia.

Stark T, Ruda-Kucerova J, Iannotti FA, D'Addario C, Di Marco R, Pekarik V, Drazanova E, Piscitelli F, Bari M, Babinska Z, Giurdanella G, Di Bartolomeo M, Salomone S, Sulcova A, Maccarrone M, Wotjak CT, Starcuk Z Jr, Drago F, Mechoulam R, Di Marzo V, Micale V.

Neuropharmacology. 2019 Mar 1;146:212-221. doi: 10.1016/j.neuropharm.2018.11.035. Epub 2018 Nov 26.

PMID:
30496751
4.

Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice.

Iannotti FA, Pagano E, Moriello AS, Alvino FG, Sorrentino NC, D'Orsi L, Gazzerro E, Capasso R, De Leonibus E, De Petrocellis L, Di Marzo V.

Br J Pharmacol. 2019 May;176(10):1568-1584. doi: 10.1111/bph.14460. Epub 2018 Sep 9.

PMID:
30074247
5.

Nociceptor plasticity: A closer look.

Pace MC, Passavanti MB, De Nardis L, Bosco F, Sansone P, Pota V, Barbarisi M, Palagiano A, Iannotti FA, Panza E, Aurilio C.

J Cell Physiol. 2018 Apr;233(4):2824-2838. doi: 10.1002/jcp.25993. Epub 2017 Jun 15. Review.

PMID:
28488779
6.

Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus.

Gamelin FX, Aucouturier J, Iannotti FA, Piscitelli F, Mazzarella E, Aveta T, Leriche M, Dupont E, Cieniewski-Bernard C, Leclair E, Bastide B, Di Marzo V, Heyman E.

J Physiol Biochem. 2016 Aug;73(3):335-347. doi: 10.1007/s13105-017-0557-1. Epub 2017 Mar 10. Erratum in: J Physiol Biochem. 2017 Oct 5;:.

PMID:
28283967
7.

Role of the endocannabinoid system in the control of mouse myometrium contractility during the menstrual cycle.

Pagano E, Orlando P, Finizio S, Rossi A, Buono L, Iannotti FA, Piscitelli F, Izzo AA, Di Marzo V, Borrelli F.

Biochem Pharmacol. 2017 Jan 15;124:83-93. doi: 10.1016/j.bcp.2016.11.023. Epub 2016 Nov 27.

PMID:
27899300
8.

Early Low-Fat Diet Enriched With Linolenic Acid Reduces Liver Endocannabinoid Tone and Improves Late Glycemic Control After a High-Fat Diet Challenge in Mice.

Demizieux L, Piscitelli F, Troy-Fioramonti S, Iannotti FA, Borrino S, Gresti J, Muller T, Bellenger J, Silvestri C, Di Marzo V, Degrace P.

Diabetes. 2016 Jul;65(7):1824-37. doi: 10.2337/db15-1279. Epub 2016 Apr 5.

9.

Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders.

Iannotti FA, Di Marzo V, Petrosino S.

Prog Lipid Res. 2016 Apr;62:107-28. doi: 10.1016/j.plipres.2016.02.002. Epub 2016 Mar 7. Review.

PMID:
26965148
10.

Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity.

Gamelin FX, Aucouturier J, Iannotti FA, Piscitelli F, Mazzarella E, Aveta T, Leriche M, Dupont E, Cieniewski-Bernard C, Montel V, Bastide B, Di Marzo V, Heyman E.

J Physiol Biochem. 2016 Jun;72(2):183-99. doi: 10.1007/s13105-016-0469-5. Epub 2016 Feb 15.

PMID:
26880264
11.

Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors.

Staiano RI, Loffredo S, Borriello F, Iannotti FA, Piscitelli F, Orlando P, Secondo A, Granata F, Lepore MT, Fiorelli A, Varricchi G, Santini M, Triggiani M, Di Marzo V, Marone G.

J Leukoc Biol. 2016 Apr;99(4):531-40. doi: 10.1189/jlb.3HI1214-584R. Epub 2015 Oct 14.

12.

Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability.

Iannotti FA, Hill CL, Leo A, Alhusaini A, Soubrane C, Mazzarella E, Russo E, Whalley BJ, Di Marzo V, Stephens GJ.

ACS Chem Neurosci. 2014 Nov 19;5(11):1131-41. doi: 10.1021/cn5000524. Epub 2014 Jul 29.

PMID:
25029033
13.

Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala.

Blasio A, Iemolo A, Sabino V, Petrosino S, Steardo L, Rice KC, Orlando P, Iannotti FA, Di Marzo V, Zorrilla EP, Cottone P.

Neuropsychopharmacology. 2013 Nov;38(12):2498-507. doi: 10.1038/npp.2013.153. Epub 2013 Jun 24.

14.

Specification of skeletal muscle differentiation by repressor element-1 silencing transcription factor (REST)-regulated Kv7.4 potassium channels.

Iannotti FA, Barrese V, Formisano L, Miceli F, Taglialatela M.

Mol Biol Cell. 2013 Feb;24(3):274-84. doi: 10.1091/mbc.E11-12-1044. Epub 2012 Dec 14.

15.

The Voltage-Sensing Domain of K(v)7.2 Channels as a Molecular Target for Epilepsy-Causing Mutations and Anticonvulsants.

Miceli F, Soldovieri MV, Iannotti FA, Barrese V, Ambrosino P, Martire M, Cilio MR, Taglialatela M.

Front Pharmacol. 2011 Feb 1;2:2. doi: 10.3389/fphar.2011.00002. eCollection 2011.

16.

Pre-synaptic BK channels selectively control glutamate versus GABA release from cortical and hippocampal nerve terminals.

Martire M, Barrese V, D'Amico M, Iannotti FA, Pizzarelli R, Samengo I, Viggiano D, Ruth P, Cherubini E, Taglialatela M.

J Neurochem. 2010 Oct;115(2):411-22. doi: 10.1111/j.1471-4159.2010.06938.x. Epub 2010 Aug 30.

17.

Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine.

Barrese V, Miceli F, Soldovieri MV, Ambrosino P, Iannotti FA, Cilio MR, Taglialatela M.

Clin Pharmacol. 2010;2:225-36. doi: 10.2147/CPAA.S15369. Epub 2010 Dec 7. Erratum in: Clin Pharmacol. 2012;4:23.

18.

Expression, localization, and pharmacological role of Kv7 potassium channels in skeletal muscle proliferation, differentiation, and survival after myotoxic insults.

Iannotti FA, Panza E, Barrese V, Viggiano D, Soldovieri MV, Taglialatela M.

J Pharmacol Exp Ther. 2010 Mar;332(3):811-20. doi: 10.1124/jpet.109.162800. Epub 2009 Dec 29.

PMID:
20040580
19.

Activation of pre-synaptic M-type K+ channels inhibits [3H]D-aspartate release by reducing Ca2+ entry through P/Q-type voltage-gated Ca2+ channels.

Luisi R, Panza E, Barrese V, Iannotti FA, Viggiano D, Secondo A, Canzoniero LM, Martire M, Annunziato L, Taglialatela M.

J Neurochem. 2009 Apr;109(1):168-81. doi: 10.1111/j.1471-4159.2009.05945.x. Epub 2009 Feb 2.

20.

Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre-synaptic muscarinic receptor activation from rat striatal synaptosomes.

Martire M, D'Amico M, Panza E, Miceli F, Viggiano D, Lavergata F, Iannotti FA, Barrese V, Preziosi P, Annunziato L, Taglialatela M.

J Neurochem. 2007 Jul;102(1):179-93. Epub 2007 Apr 16.

Supplemental Content

Loading ...
Support Center